Page 2

  • A sign for the FDA is shown in front of the headquarters building in Silver Spring, Maryland.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zimmer wins FDA’s breakthrough status for tech to prevent joint infections

    Integrating a controlled-release iodine layer into hip implants could reduce the rate of potentially fatal infections.

  • Thermo Fisher Scientific
    Image attribution tooltip
    Courtesy of Thermo Fisher Scientific
    Image attribution tooltip

    Thermo Fisher to acquire clinical trial data firm Clario for $8.9B

    The purchase is expected to complement Thermo’s clinical research services as companies are conducting more trials.

  • Three carts on wheels stand side by side, with one featuring robotic arms and another showing a screen and a controller.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J partners with Nvidia on AI for kidney stone procedures

    The medtech firm is using Nvidia’s technology in its Monarch robotic platform for urology.

  • A headshot of new Olympus CEO Bob White.
    Image attribution tooltip
    Courtesy of Olympus
    Image attribution tooltip

    Olympus execs talk about import alert, GI robot and AI

    CEO Bob White and Chief Strategy Officer Gabriela Kaynor discussed the medtech company’s quality and technology priorities after a year of change.

  • A coil-shaped device is shown moving through a tube with branching structures around it.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic links renal denervation to 3-year blood pressure reduction

    Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.

  • The robot-enhanced heart valve replacement system is depicted in an illustration that includes a patient on a table.
    Image attribution tooltip
    Courtesy of CardioPrecision
    Image attribution tooltip
    Profile

    Corcym, CardioPrecision set sights on robotic heart valve replacement

    The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the longer-term advantages of open heart surgery.

  • People walking past the AI Zone at HLTH 2025.
    Image attribution tooltip
    Emily Olsen/MedTech Dive
    Image attribution tooltip
    Deep Dive

    Health systems are racing to adopt AI. But can they prove its value?

    Measuring financial returns from AI can be challenging, experts said at the HLTH conference last week. But other metrics, like provider and patient satisfaction, are important too — and also impact providers’ bottom lines.

    AI
  • J&J, Auris, Fortis
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J awards first grants from AI surgery fund

    Mayo Clinic and QAS.AI will receive funding and mentorship to help advance their projects.

  • The HHS in DC
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    CMS calls back furloughed employees to help with Medicare, ACA enrollment periods

    Roughly 3,000 employees are coming back to work on Monday, funded by user fees as the shutdown drags into its fourth week.

  • A ship labeled "Matson" carries several large boxes in front of a port.
    Image attribution tooltip
    Justin Sullivan via Getty Images
    Image attribution tooltip

    Medtech industry closely watching Section 232 investigation

    The investigation, which could be used to impose tariffs for medical products, has raised the attention of several industry groups. Check out MedTech Dive’s roundup of coverage on the 232 probe.

  • A head shot of Accuray CEO Steve La Neve.
    Image attribution tooltip
    Permission granted by Accuray
    Image attribution tooltip

    Accuray hires Steve La Neve as CEO in transformation effort

    The radiotherapy systems maker unveiled the leadership change and strategy initiatives as it reported a preliminary fiscal first-quarter adjusted loss.